Gellin B - Search Results

1

Osterholm MT, Gellin B. Osterholm MT, et al. Among authors: gellin b. Science. 2022 Jul 19:eadd9651. doi: 10.1126/science.add9651. Online ahead of print. Science. 2022. PMID: 35857487 No abstract available.

2

The stalled response to AIDS.

Gellin BG, Rogers DE. Gellin BG, et al. Issues Sci Technol. 1992 Fall;9(1):24-8. Issues Sci Technol. 1992. PMID: 10122433 No abstract available.

3

A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.

Moore KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, Bresee JS, Friede MH, Gellin BG, Golding JP, Hart PJ, Moen A, Weller CL, Osterholm MT; Influenza Vaccines R&D Roadmap Taskforce. Moore KA, et al. Among authors: gellin bg. Vaccine. 2021 Oct 29;39(45):6573-6584. doi: 10.1016/j.vaccine.2021.08.010. Epub 2021 Sep 30. Vaccine. 2021. PMID: 34602302 Free article. Review.

4

A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy.

Moore KA, Leighton T, Ostrowsky JT, Anderson CJ, Danila RN, Ulrich AK, Lackritz EM, Mehr AJ, Baric RS, Baylor NW, Gellin BG, Gordon JL, Krammer F, Perlman S, Rees HV, Saville M, Weller CL, Osterholm MT; Coronavirus Vaccines R&D Roadmap Taskforce. Moore KA, et al. Among authors: gellin bg. Vaccine. 2023 Mar 24;41(13):2101-2112. doi: 10.1016/j.vaccine.2023.02.032. Epub 2023 Feb 21. Vaccine. 2023. PMID: 36870874 Free PMC article. Review.

5

Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings.

Ortiz JR, Neuzil KM, Ahonkhai VI, Gellin BG, Salisbury DM, Read JS, Adegbola RA, Abramson JS. Ortiz JR, et al. Vaccine. 2012 Nov 26;30(50):7134-40. doi: 10.1016/j.vaccine.2012.09.034. Epub 2012 Sep 29. Vaccine. 2012. PMID: 23026690

6

Seasonal and pandemic influenza vaccine: demand, supply and vaccine availability.

Gellin BG, Ampofo WK. Gellin BG, et al. Vaccine. 2014 Dec 12;32(52):7037-9. doi: 10.1016/j.vaccine.2014.10.062. Epub 2014 Nov 5. Vaccine. 2014. PMID: 25444824 No abstract available.

7

Addressing vaccine hesitancy: The potential value of commercial and social marketing principles and practices.

Nowak GJ, Gellin BG, MacDonald NE, Butler R; SAGE Working Group on Vaccine Hesitancy. Nowak GJ, et al. Vaccine. 2015 Aug 14;33(34):4204-11. doi: 10.1016/j.vaccine.2015.04.039. Epub 2015 Apr 18. Vaccine. 2015. PMID: 25900132 Free article.

8

Preparing for the unpredictable: The continuing need for pandemic influenza preparedness.

Gellin BG, Qadri F. Gellin BG, et al. Vaccine. 2016 Oct 26;34(45):5391-5392. doi: 10.1016/j.vaccine.2016.09.023. Epub 2016 Sep 24. Vaccine. 2016. PMID: 27682508 Free PMC article. No abstract available.

9

Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015.

Shen AK, Kelman JA, Warnock R, Zhang W, Brereton S, McKean S, Wernecke M, Chu S, Gellin BG. Shen AK, et al. Vaccine. 2017 Dec 19;35(52):7302-7308. doi: 10.1016/j.vaccine.2017.10.105. Epub 2017 Nov 10. Vaccine. 2017. PMID: 29132990

10

The National Vaccine Advisory Committee at 30: Impact and opportunity.

Thompson KM, Gellin BG, Hinman AR, Orenstein WA. Thompson KM, et al. Vaccine. 2018 Mar 7;36(11):1330-1344. doi: 10.1016/j.vaccine.2018.01.068. Vaccine. 2018. PMID: 29422369 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page